171 related articles for article (PubMed ID: 30076959)
1. Pharmacological blockade of CXCR3 by (±)-NBI-74330 reduces neuropathic pain and enhances opioid effectiveness - Evidence from in vivo and in vitro studies.
Piotrowska A; Rojewska E; Pawlik K; Kreiner G; Ciechanowska A; Makuch W; Zychowska M; Mika J
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3418-3437. PubMed ID: 30076959
[TBL] [Abstract][Full Text] [Related]
2. Dataset of (±)-NBI-74330 (CXCR3 antagonist) influence on chemokines under neuropathic pain.
Piotrowska A; Rojewska E; Pawlik K; Kreiner G; Ciechanowska A; Makuch W; Mika J
Data Brief; 2018 Dec; 21():1145-1150. PubMed ID: 30456228
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the Effects of Chemokine Receptors CXCR2 and CXCR3 Pharmacological Modulation in Neuropathic Pain Model-
Piotrowska A; Ciapała K; Pawlik K; Kwiatkowski K; Rojewska E; Mika J
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681732
[TBL] [Abstract][Full Text] [Related]
4. Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy.
Kwiatkowski K; Pawlik K; Ciapała K; Piotrowska A; Makuch W; Mika J
Front Immunol; 2020; 11():615327. PubMed ID: 33408720
[TBL] [Abstract][Full Text] [Related]
5. Chemokines CCL2 and CCL7, but not CCL12, play a significant role in the development of pain-related behavior and opioid-induced analgesia.
Kwiatkowski K; Popiolek-Barczyk K; Piotrowska A; Rojewska E; Ciapała K; Makuch W; Mika J
Cytokine; 2019 Jul; 119():202-213. PubMed ID: 31003094
[TBL] [Abstract][Full Text] [Related]
6. Chemokine CXCL10/CXCR3 signaling contributes to neuropathic pain in spinal cord and dorsal root ganglia after chronic constriction injury in rats.
Chen Y; Yin D; Fan B; Zhu X; Chen Q; Li Y; Zhu S; Lu R; Xu Z
Neurosci Lett; 2019 Feb; 694():20-28. PubMed ID: 30448292
[TBL] [Abstract][Full Text] [Related]
7. Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats.
Kwiatkowski K; Piotrowska A; Rojewska E; Makuch W; Jurga A; Slusarczyk J; Trojan E; Basta-Kaim A; Mika J
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():68-78. PubMed ID: 26190414
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the pharmacokinetic/pharmacodynamic relationship of a small molecule CXCR3 antagonist, NBI-74330, using a murine CXCR3 internalization assay.
Jopling LA; Watt GF; Fisher S; Birch H; Coggon S; Christie MI
Br J Pharmacol; 2007 Dec; 152(8):1260-71. PubMed ID: 17982480
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological Blockade of Spinal CXCL3/CXCR2 Signaling by NVP CXCR2 20, a Selective CXCR2 Antagonist, Reduces Neuropathic Pain Following Peripheral Nerve Injury.
Piotrowska A; Rojewska E; Pawlik K; Kreiner G; Ciechanowska A; Makuch W; Nalepa I; Mika J
Front Immunol; 2019; 10():2198. PubMed ID: 31616413
[TBL] [Abstract][Full Text] [Related]
10. Blockade of CC Chemokine Receptor Type 3 Diminishes Pain and Enhances Opioid Analgesic Potency in a Model of Neuropathic Pain.
Pawlik K; Ciechanowska A; Ciapała K; Rojewska E; Makuch W; Mika J
Front Immunol; 2021; 12():781310. PubMed ID: 34795678
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist.
Heise CE; Pahuja A; Hudson SC; Mistry MS; Putnam AL; Gross MM; Gottlieb PA; Wade WS; Kiankarimi M; Schwarz D; Crowe P; Zlotnik A; Alleva DG
J Pharmacol Exp Ther; 2005 Jun; 313(3):1263-71. PubMed ID: 15761110
[TBL] [Abstract][Full Text] [Related]
12. The involvement of iron responsive element (-) divalent metal transporter 1-mediated the spinal iron overload via CXCL10/CXCR3 pathway in neuropathic pain in rats.
Xu W; Liu W; Yu W
Neurosci Lett; 2019 Feb; 694():154-160. PubMed ID: 30521948
[TBL] [Abstract][Full Text] [Related]
13. Spinal CXCL9 and CXCL11 are not involved in neuropathic pain despite an upregulation in the spinal cord following spinal nerve injury.
Wu XB; He LN; Jiang BC; Shi H; Bai XQ; Zhang WW; Gao YJ
Mol Pain; 2018; 14():1744806918777401. PubMed ID: 29712506
[TBL] [Abstract][Full Text] [Related]
14. Promoted Interaction of C/EBPα with Demethylated Cxcr3 Gene Promoter Contributes to Neuropathic Pain in Mice.
Jiang BC; He LN; Wu XB; Shi H; Zhang WW; Zhang ZJ; Cao DL; Li CH; Gu J; Gao YJ
J Neurosci; 2017 Jan; 37(3):685-700. PubMed ID: 28100749
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.
Basset L; Chevalier S; Danger Y; Arshad MI; Piquet-Pellorce C; Gascan H; Samson M
J Mol Med (Berl); 2015 Dec; 93(12):1355-67. PubMed ID: 26199110
[TBL] [Abstract][Full Text] [Related]
16. CCR4 antagonist (C021) influences the level of nociceptive factors and enhances the analgesic potency of morphine in a rat model of neuropathic pain.
Bogacka J; Popiolek-Barczyk K; Pawlik K; Ciechanowska A; Makuch W; Rojewska E; Dobrogowski J; Przeklasa-Muszynska A; Mika J
Eur J Pharmacol; 2020 Aug; 880():173166. PubMed ID: 32407723
[TBL] [Abstract][Full Text] [Related]
17. Blockade of Toll-Like Receptors (TLR2, TLR4) Attenuates Pain and Potentiates Buprenorphine Analgesia in a Rat Neuropathic Pain Model.
Jurga AM; Rojewska E; Piotrowska A; Makuch W; Pilat D; Przewlocka B; Mika J
Neural Plast; 2016; 2016():5238730. PubMed ID: 26962463
[TBL] [Abstract][Full Text] [Related]
18. New insights into the analgesic properties of the XCL1/XCR1 and XCL1/ITGA9 axes modulation under neuropathic pain conditions - evidence from animal studies.
Ciechanowska A; Rojewska E; Piotrowska A; Barut J; Pawlik K; Ciapała K; Kreiner G; Mika J
Front Immunol; 2022; 13():1058204. PubMed ID: 36618360
[TBL] [Abstract][Full Text] [Related]
19. CXCL10/CXCR3 Signaling in the DRG Exacerbates Neuropathic Pain in Mice.
Kong YF; Sha WL; Wu XB; Zhao LX; Ma LJ; Gao YJ
Neurosci Bull; 2021 Mar; 37(3):339-352. PubMed ID: 33196963
[TBL] [Abstract][Full Text] [Related]
20. Blockade of IL-18 signaling diminished neuropathic pain and enhanced the efficacy of morphine and buprenorphine.
Pilat D; Piotrowska A; Rojewska E; Jurga A; Ślusarczyk J; Makuch W; Basta-Kaim A; Przewlocka B; Mika J
Mol Cell Neurosci; 2016 Mar; 71():114-24. PubMed ID: 26763728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
